Department of Orthopaedic Surgery, University of South Alabama, 3421 Medical Park Drive, Mobile, AL 36693, USA.
J Bone Joint Surg Am. 2010 Mar;92(3):609-18. doi: 10.2106/JBJS.H.01847.
BACKGROUND: Several mechanisms have been proposed to explain toxicity of local anesthetics to chondrocytes, including the blockade of potassium channels and mitochondrial injury. The purposes of this investigation were to study the effects of lidocaine, bupivacaine, and ropivacaine on human chondrocyte viability and mitochondrial function in vitro and to characterize the type of cell death elicited following exposure. METHODS: Primary chondrocyte cultures from patients with osteoarthritis undergoing knee replacement were treated with saline solution and the following concentrations of local anesthetics: 2%, 1%, and 0.5% lidocaine, 0.5% and 0.25% bupivacaine, and 0.5% and 0.2% ropivacaine for one hour. Cell viability and apoptosis were measured by flow cytometry at twenty-four hours and 120 hours after treatment. Nuclear staining and caspase 3 and 9 cleavage assays (Western blot) were used to further establish the induction of apoptosis. Mitochondrial dysfunction was evaluated by the accumulation of mitochondrial DNA damage (quantitative Southern blot), changes in adenosine triphosphate production (bioluminescence kit), and mitochondrial protein levels (Western blot analysis). RESULTS: Exposure of primary human chondrocytes to a 2% concentration of lidocaine caused massive necrosis of chondrocytes after twenty-four hours, 1% lidocaine and 0.5% bupivacaine caused a detectable, but not significant, decrease in viability after twenty-four hours, while 0.5% lidocaine, 0.25% bupivacaine, and both concentrations of ropivacaine (0.5% and 0.2%) did not affect chondrocyte viability. Flow cytometry analysis of chondrocytes 120 hours after drug treatment revealed a significant decrease in viability (p < 0.05) with a concomitant increase in the number of apoptotic cells at all concentrations of lidocaine, bupivacaine, and ropivacaine analyzed, except 0.2% ropivacaine. Apoptosis was verified by observation of condensed and fragmented nuclei and a decrease in procaspase 3 and 9 levels. Local anesthetics induced mitochondrial DNA damage and a decrease in adenosine triphosphate and mitochondrial protein levels. CONCLUSIONS: Lidocaine, bupivacaine, and ropivacaine cause delayed mitochondrial dysfunction and apoptosis in cultured human chondrocytes.
背景:已经提出了几种解释局部麻醉药对软骨细胞毒性的机制,包括钾通道阻断和线粒体损伤。本研究的目的是研究利多卡因、布比卡因和罗哌卡因对体外人软骨细胞活力和线粒体功能的影响,并对暴露后引起的细胞死亡类型进行特征描述。
方法:对接受膝关节置换术的骨关节炎患者的原代软骨细胞进行生理盐水和以下浓度的局部麻醉剂处理:2%、1%和 0.5%利多卡因、0.5%和 0.25%布比卡因以及 0.5%和 0.2%罗哌卡因,处理时间为 1 小时。在治疗后 24 小时和 120 小时通过流式细胞术测量细胞活力和细胞凋亡。核染色和 caspase 3 和 9 切割测定(Western blot)用于进一步建立凋亡诱导。通过线粒体 DNA 损伤的积累(定量 Southern blot)、三磷酸腺苷(adenosine triphosphate,ATP)产生的变化(生物发光试剂盒)和线粒体蛋白水平(Western blot 分析)评估线粒体功能障碍。
结果:将原代人软骨细胞暴露于 2%浓度的利多卡因中 24 小时后导致软骨细胞大量坏死,1%利多卡因和 0.5%布比卡因在 24 小时后可检测到但不显著降低细胞活力,而 0.5%利多卡因、0.25%布比卡因和两种浓度的罗哌卡因(0.5%和 0.2%)不影响软骨细胞活力。药物处理 120 小时后,对软骨细胞进行流式细胞术分析显示,所有分析的利多卡因、布比卡因和罗哌卡因浓度均显著降低细胞活力(p < 0.05),同时增加了凋亡细胞的数量,除了 0.2%罗哌卡因。通过观察浓缩和碎片化的核以及 caspase 3 和 9 水平的降低来验证凋亡。局部麻醉剂诱导线粒体 DNA 损伤和三磷酸腺苷和线粒体蛋白水平降低。
结论:利多卡因、布比卡因和罗哌卡因导致培养的人软骨细胞延迟的线粒体功能障碍和凋亡。
J Bone Joint Surg Am. 2013-1-16
J Bone Joint Surg Am. 2008-5
Clin Orthop Relat Res. 2010-8-11
Int J Mol Sci. 2024-12-16
BMC Oral Health. 2024-10-29
BMC Musculoskelet Disord. 2023-7-15